The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours. After-hours trades for Sana Biotechnology Inc. (SANA) shows that investor sentiment remained intact, with the stock’s consolidated last price rising by $0.13, or 3.54%, to $3.80. The Sana Biotechnology Inc. has recorded 247,793 volume in the after hours trading session. Most recently, Yahoo Finance reported about the stock as it publicized that Sana Biotechnology to Present at the Guggenheim Healthcare Talks 5th Annual Oncology Conference.
From Robots to Self-Driving Cars: 5 AI Stocks to Consider for Your Portfolio
The artificial intelligence (AI) revolution is already here and it's about to change everything we know about everything. With the global market for AI projected to grow from $137 billion in 2022 to over $1.81 trillion by 2030, there's never been a better time to invest in this burgeoning industry. That's why we've compiled a list of the Top 5 AI Stocks to Buy for 2023. These companies are at the forefront of the AI revolution, and have the potential to deliver huge returns to investors like you.
Get our free report, "Top 5 AI Stocks to Buy for 2023".
Sana Biotechnology Inc. is listed on the NASDAQ as a member of the Healthcare sector and is a part of the Biotechnology industry. At the end of the last regular session, the stock closed at $3.67 and fluctuated between $3.8300 as its day high and $3.6300 as its day low. The current market capitalization of Sana Biotechnology Inc. is $742.77M. A total of 1.44 million shares were traded on the day, compared to an average of 980.09K shares.
Additionally, investors take into account insider trades when predicting how a stock will perform. During the recent three months, SANA has seen 2 BUY and 0 SELL insider trades, representing the acquisition of 7,238 and the disposition of 0 shares. Over the last 12 months, there were 11 BUYs and 0 SELLs from insiders. Insiders purchased 114,254 shares during that period but sold 0.
In the most recent transaction, Yang Patrick Y bought 28,000 shares of SANA for 7.30 per share on Mar 21. After the transaction, the Director now owns 174,250 company shares.
Though price targets are rarely accurate, they can exert some influence from time to time and were often accepted as valuable by the market. According to analysts who have offered 12-month price targets for SANA in the last 3 months, the mean price target is $9.25 with high estimates of $13.00 and low estimates of $5.00. In terms of 52-week highs and lows, SANA has a high of $9.60 and a low of $3.15.
As of this writing, SANA has an earnings estimate of -$0.51 per share for the current quarter. EPS was calculated based on a consensus of 2 estimates, with a high estimate of -$0.51 per share and a lower estimate of -$0.52. The company reported an EPS of -$0.39 in the last quarter, which was 23.50% higher than expectations of -$0.51.
Balance Sheet Annually/Quarterly
A balance sheet is a report that shows the company’s assets and liabilities. In addition, it shows how much equity investors have invested in the company. Investors can determine the company’s prospects by calculating its financial ratios based on this information.
It may be riskier to trade before market opening and after market closing than during regular market hours. Since issuers often announce critical financial information outside regular trading hours. Extended-hours trading may result in wider spreads for particular securities due to lower liquidity and higher volatility. Currently, 4 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for SANA is Buy with a score of 4.00. A total of 2 analysts rated the stock as Buy while 0 rated it as Overweight while 2 rated it as Hold. Among the other participants, 0 thought the stock was Underweight and 0 thought it should be Sold.